Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
MRK
Merck & Co., Inc.
NYSE · Pharmaceutical Preparations
Last close
$142.38
· 2026-10-08
ABOUT
Exchange
NYSE
Sector
Healthcare
Industry
Pharmaceutical Preparations
Market cap
$358.50B
RECENT INSIDER TRADES
2026-08-13
· Guindo Chirfi
(EVP, Access, Policy & Comms)
· SELL
2026-08-13
· Zachary Jennifer
(EVP, General Counsel)
· OTHER
2026-08-13
· Zachary Jennifer
(EVP, General Counsel)
· SELL
2026-08-12
· DeLuca Richard R.
(EVP&Pres, Merck Animal Heallth)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
4,185
Shares held
2,488,434,328
Value
$303.16B
Percent of shares outstanding
100.86%
As of quarter end
2026-09-30
RECENT CONGRESSIONAL TRADES
2026-08-19
· Hon. Maria Elvira Salazar · BUY
· $15,001 - $50,000
2026-08-07
· Ro Khanna · BUY
· $15,001 - $50,000
2026-03-27
· Alan Armstrong · SELL
· $15,001 - $50,000
2025-08-28
· Hon. Marjorie Taylor Greene · BUY
· $1,001 - $15,000
2025-06-13
· Hon. Julie Johnson · BUY
· $1,001 - $15,000
RECENT NEWS
Merck's experimental eye drug meets goal in trial, but raises safety concerns
Merck’s remigromig meets non-inferiority goal in DME trial
Merck barred from making subcutaneous Keytruda in 8 European countries
Guggenheim reiterates Merck rating ahead of Q3 earnings
Halozyme stock rises after winning injunction against Merck
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Merck & Co., Inc. (MRK) · Stock Price, Insider Trades, Congress Trades · CatalystPit